Clinical Trials

52 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT04917263 2021-06-08

IMMUNOREACT2

544 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT01476410 2020-02-17

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

48 enrolled

Lymphoid

Hodgkin Disease

NCT04122131 2019-10-10

Fibrotic Focus in Breast Cancer

250 enrolled

Breast Neoplasms

NCT03820921 2019-01-29

SUCCESS

30 enrolled

Pancreatic Neoplasms

NCT03692533 2018-10-02

Role of Geminin and Mcm-2 in Prognosis of Renal Cell Carcinoma

Phase NA Unknown

80 enrolled

Carcinoma, Renal Cell

NCT03078959 2017-03-14

Prognostic Value of PD-L1 in NSCLC

350 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01004796 2016-02-29

Study of Biomarkers in Tissue Samples From Patients With Breast Cancer

Breast Neoplasms

NCT02656134 2016-01-14

Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)

55 enrolled

Adenomatous Polyposis Coli

NCT02353988 2015-02-03

Arbre

60 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Phase NA Unknown

12 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00553124 2014-01-10

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Phase 3 Unknown

3,400 enrolled

Urinary Bladder Neoplasms

NCT00671476 2014-01-10

Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery

Phase NA Unknown

30 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00717587 2014-01-10

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

20 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00463034 2013-12-18

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

1,800 enrolled

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

120 enrolled

Breast Neoplasms

NCT00897039 2013-09-20

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

60 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

87 enrolled

CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00625625 2013-09-17

Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer

225 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00082979 2013-08-26

Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer

60 enrolled

Breast Neoplasms

NCT00083018 2013-08-26

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

100 enrolled

Breast Neoplasms

NCT00899262 2013-08-26

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

300 enrolled

Thoracic

Lung Neoplasms, Tobacco Use Disorder

NCT00445783 2013-08-12

Study of Families With Melanoma

3,700 enrolled

Dermatologic

Melanoma

NCT01118039 2013-08-07

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

41 enrolled

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

957 enrolled

Breast Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

54 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01150682 2011-04-29

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

865 enrolled

Gynecologic

Endometrial Neoplasms

NCT00357617 2010-12-24

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Phase 1/2 Unknown

24 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01074398 2010-02-24

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

513 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy